期刊文献+

N端脑利钠肽前体在儿童左向右分流先天性心脏病中评价肺动脉高压的价值 被引量:6

原文传递
导出
摘要 目的评价血浆N端脑利钠肽前体(NT-proBNP)在儿童常见左向右分流先天性心脏病(CHD)中评价肺动脉高压(PAH)的价值。方法 2006~2010年54例介入治疗住院的左向右分流CHD伴PAH的患儿,男25例,女29例,年龄(7.5±5.2)岁(0.5~15岁)。单纯室间隔缺损20例,房间隔缺损11例,动脉导管未闭23例(含并主动脉缩窄1例),以右心导管检查测得肺动脉收缩压(PASP)≥30mmHg(1mmHg=0.133kPa)为PAH,30~40mmHg为轻度,41~70mmHg为中度,≥70mmHg为重度。心功能改良Ross评分>3,心脏超声测量左心室射血分数(LVEF)<50%以及右心室流出道狭窄、血肌酐>115μmol/L的患儿排除在外。血浆NT-proBNP浓度测定应用电化学发光双抗体免疫夹心分析法。采用SPSS13.0软件包进行统计分析血浆NT-proBNP浓度与PASP的相关性和血浆NT-proBNP浓度诊断PAH的敏感性和特异性及ROC曲线。结果 PAH轻度15例、中度25例、重度14例,血浆NT-proBNP浓度(中位数)分别为99.9(75.8~131.6)pg/ml、437.3(194.6~1815.5)pg/ml、2740.0(505.9~3508.2)pg/ml(P<0.001),与PASP呈正相关(r=0.57,P=0.001)。血浆NT-proBNP浓度为128.7pg/ml时,诊断PAH的敏感性和特异性分别为93%和100%,ROC曲线下面积0.97(95%可信限0.92~1.00,非参数检验P=0.000)。血浆NT-proBNP浓度为1456.8pg/ml时,诊断重度PAH的敏感性和特异性分别为46%、83%,ROC曲线下面积0.79(95%可信限0.67~0.91,非参数检验P=0.000)。结论左向右分流CHD患儿血浆NT-ProBNP水平能一定程度反映肺动脉压力的变化,可作为评价PAH的生化指标。
出处 《中华临床医师杂志(电子版)》 CAS 2012年第15期199-200,共2页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献11

  • 1Munagala VK,Burnett JC Jr,Redfield MM. The natriuretic peptides in cardiovascular medicine[J].Current Problems in Cardiology,2004,(12):707-769.doi:10.1016/j.cpcardiol.2004.07.002.
  • 2Bernus A,Wagner BD,Accurso F. Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension[J].Chest,2009,(3):745-751.doi:10.1378/chest.08-0187.
  • 3Reynolds EW,Ellington JG,Vranicar M. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn[J].Pediatrics,2004.1297-1304.
  • 4武育蓉,陈树宝,黄美蓉,张玉奇,孙锟,陈笋.氨基末端脑利钠肽前体在室间隔缺损合并心力衰竭诊断中的价值[J].中华儿科杂志,2005,43(3):161-164. 被引量:37
  • 5李运泉,陈国桢,覃有振,刘东红,张式鸿,王慧深,李格丽.小儿心力衰竭N端脑利钠肽原的临床价值[J].中华急诊医学杂志,2008,17(3):285-288. 被引量:10
  • 6Badano LP,Ginghina C,Easaw J. Right ventricle in pulmonary arterial hypertension:haemodynamics,structural changes,imaging,and proposal of a study protocol aimed to assess remodelling and treatment effects[J].European Journal of Echocardiography,2010.27-37.doi:10.1093/ejechocard/jep152.
  • 7McGoon M,Gutterman D,Steen V. Screening,early detection,and diagnosis of pulmonary arterial hypertension:ACCP evidence-based clinical practice guidelines[J].Chest,2004.14S-34S.
  • 8Casserly B,Klinger JR. Brain natriuretic peptide in pulmonary arterial hypertension:biomarker and potential therapeutic agent[J].Drug Des Devel Ther,2009.269-287.
  • 9Souza R,Bogossian HB,Humbert M. N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension[J].European Respiratory Journal,2005,(3):509-513.doi:10.1183/09031936.05.00100504.
  • 10Williams MH,Handler CE,Akram R. Role of N-terminal brain natriuretic peptide(N-TproBNP)in scleroderma-associated pulmonary arterial hypertension[J].European Heart Journal,2006.1485-1494.

二级参考文献16

  • 1武育蓉,陈树宝,黄美蓉,张玉奇,孙锟,陈笋.氨基末端脑利钠肽前体在室间隔缺损合并心力衰竭诊断中的价值[J].中华儿科杂志,2005,43(3):161-164. 被引量:37
  • 2姚渭清,陈树宝,周爱卿,王荣发,孙锟,黄美蓉,邓杏飞,高伟.室间隔缺损合并心力衰竭的机理研究[J].中华儿科杂志,1994,32(3):139-141. 被引量:23
  • 3梅冰,霍正禄,何青青,王美堂,曹晖,何建.血浆B型钠尿肽对急诊监护室患者心功能不全的诊断意义[J].中华急诊医学杂志,2007,16(3):287-290. 被引量:8
  • 4Mir TS, Marohn S, Laer S, et al. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure [ J ]. Pediatrics. 2002, 110 (6): e76.
  • 5Pfister R, Scholz M, Wielckens K, et al. The value of natriuretic peptides NT-pro-BNP and BNP for the assessment of left-ventricular volume and function. A prospective study of 150 patients [J]. Dtsch Med Wochenschr, 2002, 127 (49): 2605-2609.
  • 6Nir A, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology [J]. J Card Fail, 2005, 11 (5 Suppl): S76-80.
  • 7Ross RD. Grading the graders of congestive heart failure in children [J]. J Pediatr, 2001, 138 (5): 618-620.
  • 8Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT- proBNP in clinical routine [J]. Heart, 2006, 92 (6): 843-849.
  • 9Mir TS, Marohn S, Laer S,et al. Plasma concentrations of N-terminal pro-brain natriurtic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure.Pediatrics,2002,110:e76.
  • 10Kawai K,Hata K,Takaoka H,et al. Plasma brain natriuretic peptide as a noval therapetic indicator in idiopathic dilated cardiomyopathy during β-blocker therapy: a potential of hormone-guided treatment.Am Heart J,2001,141:925-932.

共引文献44

同被引文献62

  • 1Komai H, Adatia IT, Elliott M J, et al. Increased plasma Ievels of endothelin after cardiopulmonary bypass in patients with pulmonary hyperWnsion nd congenital he disease[J]. J Thorae Cardiovasc Surg, 1993, 106: 473- 478.
  • 2Inglessis I, Landzberg MJ.Interventional catheterization in adult congenital heart disease[J].Circulation, 2007, 115 (12):1622-1633.
  • 3Diller GP, Gatzoulis MA.Pulmonary vascular disease in adults with congenital heart disease[J].Circulation, 2007, 115 (8) :1039-1050.
  • 4Munagala VK, Burnett JC Jr, Redfield MM.The natriuretic peptides in cardiovascular medicine[J].Curr Probl Cardiol, 2004,29(12) :707-769.
  • 5Bernus A, Wagner BD, Accurso F, et al.Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension[J].Chest, 2009,135 (3) :745-751.
  • 6Reynolds EW, Ellington JG, Vranicar M, et al.Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn[J].Pediatrics, 2004,114(5) :1297-1304.
  • 7Currie PJ, Seward JB, Chan KL, et al.Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients[J].J Am Coll Cardiol, 1985,6(4) :750-756.
  • 8Galiè N, Hoeper MM, Humbert M, et al.Guidelines for the diagnosis and treatment of pulmonary hypertension : the Task Force for the Diagnosis andTreatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the EuropeanRespiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)[J].Eur Heart J, 2009,30 (20) :2493-2537.
  • 9Cantinotti M, Vittorini S, Storti S, et al.Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with congenital heart diseases[J].J Cardiovasc Med (Hagerstown) , 2009,10 (9) :706-713.
  • 10Nagaya N, Nishikimi T, Okano Y, et al.Plasma brain natriuretic peptide levels increase in proportion to the extend of fight ventricular dysfunction in pulmonary hypertension[J].J Am Coll Cardiol, 1998,31 (1) :202-208.

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部